MKI67 and colorectal carcinoma: Relatively to CRC, survival of patients that are negative for Ki-67 is 65.6% with a medium of survival of 65.0 ± 2.8 months after diagnosis, while Ki-67 positive patients present a survival of 62.3% with a medium of survival of 62.1 ± 2.1 months after diagnosis, such as is shown in Table 5.